Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Q32 Bio Inc. issued 150,000 shares of Common Stock of warrant to accredited investors (PIPE Investors) for $7.9999 per Pre-Funded Warrant.
- Security
- warrant
- Shares
- 150,000 shares of Common Stock
- Purchaser
- accredited investors (PIPE Investors)
- Consideration
- $7.9999 per Pre-Funded Warrant
Exact text from the filing
and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase 150,000 shares of Common Stock (the “Warrant Shares”) (the “Offering”). The Shares were sold at a price of $8.00 per Share, and the Pre-Funded Warrants were sold at a price of $7.9999 per Pre-Funded Warrant, which is the price per Share less an exercise price of $0.0001 per Warrant Share.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Q32 Bio Inc. issued 6,725,000 shares of common stock to accredited investors (PIPE Investors) for $8.00 per Share.
- Security
- common stock
- Shares
- 6,725,000 shares
- Purchaser
- accredited investors (PIPE Investors)
- Consideration
- $8.00 per Share
Exact text from the filing
and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase 150,000 shares of Common Stock (the “Warrant Shares”) (the “Offering”). The Shares were sold at a price of $8.00 per Share, and the Pre-Funded Warrants were sold at a price of $7.9999 per Pre-Funded Warrant, which is the price per Share less an exercise price of $0.0001 per Warrant Share.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Q32 Bio Inc. entered into Securities Purchase Agreement with selected investors that qualify as "accredited investors" valued at approximately $55 million (effective 2026-05-26).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- selected investors that qualify as "accredited investors"
- Value
- approximately $55 million
- Effective
- 2026-05-26
Exact text from the filing
On May 26, 2026, Q32 Bio Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with selected investors that qualify as “accredited investors” (collectively, the “PIPE Investors”), as defined in Rule 501(a) of Regulation D promulgated under the United States Securities Act of 1933, as amended (the “Securities Act”), to sell to the PIPE Investors an aggregate of (i) 6,725,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase 150,000 shares of Common Stock (the “Warrant Shares”) (the “Offering”).
View on SEC.gov